Skip to main content

Table 3 Clinical characteristics of patients/probands with identified likely pathogenic mutation

From: New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease

Patient/Proband

Likely pathogenic

sequence changes

Gender

F/M

Age of ESRD (years)

Creatinine (μmol/l)

HT

Y/N

HD 53

p.Q3488X

F

48

Y

HD 15

Splice (c.10821+1G>C)

and p.C3694R

F

45

Y

Fam.340

p.L3617P

F

52 y- creat. 350

N

Fam.173

p.S3693L

F

55

Y

Fam.329

p.R3753Q

F

58 y- creat. 230

N

HD 2

p.Y3781_D3782del

M

42

Y

HD 12

p.D3782EfsX46

M

45

Y

HD 23

p.W3806X

F

42

Y

HD 41

p.A3875PfsX62

F

44

Y

Fam. 256

p.E3918X

F

50

N

HD 10

p.Q4011X

F

48

Y

Fam. 323

p.L4019X

M

50 y- creat. 104

Y

Fam. 281

p.R4021X

F

50

Y

HD 31

p.R4021X

M

36

Y

Fam.387

p.Q4042X

M

32 y- creat. 154

Y

Fam. 237

p.Q4216H

F

42

Y

HD 38

p.R4228P

M

47

Y

HD 1

p.Q4231X

F

50

Y

HD 40

p.Q4242X

F

50

Y

  1. cDNA numbering is based on reference database: The Polycystic Kidney Disease Mutation Database (PKDB server) [5].
  2. HD - patients from dialysis centres in Czech Republic, F - female, M - male, HT - Hypertension, Y - yes, N - no;